Autumn Glory Partners’s Bristol-Myers Squibb BMY Stock Holding History

Autumn Glory Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7,410	Closed	-$449K	–	217
2026 Q1	$449K	Buy	+7,410	New	+$432K	0.17%	133
2025 Q1	–	Sell	-4,001	Closed	-$226K	–	177
2024 Q4	$226K	Sell	4,001 -68	-2%	-$3.8K	0.11%	160
2024 Q3	$211K	Buy	+4,069	New	+$191K	0.08%	193
2022 Q3	–	Sell	-3,293	Closed	-$254K	–	154
2022 Q2	$254K	Hold	3,293	–	–	0.19%	115
2022 Q1	$240K	Sell	3,293 -368	-10%	-$24.7K	0.14%	136
2021 Q4	$228K	Buy	+3,661	New	+$215K	0.1%	190

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Autumn Glory Partners's BMY Position: Q2 2026 in Review

Autumn Glory Partners sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 7,410 shares — an estimated $449K sold.

Autumn Glory Partners first reported a position in BMY in Q4 2021 and held it in 6 quarters. The position peaked at $449K in Q1 2026. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Autumn Glory Partners reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
Autumn Glory Partners sold 7,410 Bristol-Myers Squibb shares in Q2 2026, an estimated $449K.
Autumn Glory Partners first reported a position in Bristol-Myers Squibb in Q4 2021 and held it in 6 quarters.
Autumn Glory Partners's Bristol-Myers Squibb position peaked at $449K in Q1 2026.
2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Autumn Glory Partners's 13F filing for Q2 2026, filed 3 Aug 2026.